Biotech Investing BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
Biotech Investing BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+ for Breast Cancer
Biotech Investing BriaCell's Bria-OTS+ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal
Biotech Investing BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+ for Cancer
